Skip to Content
Merck
  • A cluster of meningococcal disease caused by rifampicin-resistant C meningococci in France, April 2012.

A cluster of meningococcal disease caused by rifampicin-resistant C meningococci in France, April 2012.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (2012-09-04)
I Mounchetrou Njoya, Ae Deghmane, Mk Taha, H Isnard, I Parent du Chatelet
ABSTRACT

In April 2012, a cluster of two cases of meningococcal disease caused by rifampicin-resistant C meningococci was reported in the Champagne-Ardenne region, France. The two cases occurred in a student population living in the same town but studying at different schools. Bacteriological and epidemiological investigations of cases have shown that the isolates of both cases were non-differentiable.

MATERIALS
Product Number
Brand
Product Description

Cefotaxime sodium, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Cefotaxime sodium salt, suitable for plant cell culture, BioReagent, powder or crystals
Sigma-Aldrich
Cefotaxime sodium salt, potency: 916-964 μg per mg